Technology News and Research

RSS

Closed-loop artificial pancreas could fight against Type 1 diabetes

Engineering researchers at Rensselaer Polytechnic Institute are combining automation techniques from oil refining and other diverse areas to help create a closed-loop artificial pancreas. The device will automatically monitor blood sugar levels and administer insulin to patients with Type 1 diabetes, and aims to remove much of the guesswork for those living with the chronic disease.

8 Jun 2011

Cooperation is key to finding global food security

"We need a global approach to achieving food security," Tom Daschle, former Senate majority leader and chair of the DuPont Advisory Committee on Agricultural Innovation and Productivity for the 21st Century, writes in a Politico opinion piece.

8 Jun 2011

Self-assembling mini devices now enlisted in nanomedicine revolution

Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform for combining targeting and imaging agents, and enabling membrane barriers to be crossed as well as making drug and imaging agent combination therapies possible.

8 Jun 2011

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.

8 Jun 2011

Lethal malaria parasite has biochemical weakness

Every year, 10,000 pregnant women and up to 200,000 newborn babies are killed by the malaria parasite. Doctors all around the globe have for years been looking in vain for a medical protection, and now researchers from the University of Copenhagen have found the biochemically weakness of the lethal malaria parasite, and will now start developing a vaccine to combat pregnancy related malaria.

8 Jun 2011

Vaccine candidate produces immune response to antigen in all strains of influenza A

A universal influenza vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu vaccine annually to match predicted strains, with major implications for global health.

8 Jun 2011

New Westchester Montefiore Laser and Eye Center to offer ophthalmology services

The new Montefiore Laser and Eye Center recently opened its doors to provide comprehensive care to Westchester patients at the Montefiore Medical Specialists of Westchester in Scarsdale, New York. Seven board-certified ophthalmologists from the Department of Ophthalmology and Visual Sciences at Montefiore Medical Center provide patients with specialty emphasis in pediatric ophthalmology, oculoplastic surgery, glaucoma, cornea and laser refractive surgery.

8 Jun 2011

HP partners with nonprofit to help detect malaria outbreaks, improve health monitoring in Botswana

Hewlett-Packard on Monday announced it will provide "smartphones and cloud computing technology to nonprofit group Positive Innovation for the Next Generation (PING)" to help improve health monitoring and malaria detection in Botswana, Venture Beat reports.

8 Jun 2011

As health care technology advances, costs increase

The device industry has launched an aggressive campaign to avoid tighter Food and Drug Administration rules that would help generate the information needed to show whether newer devices are actually superior to the ones they replace.

8 Jun 2011

Magnetic field can reduce blood viscosity, prevent heart attacks

If a person's blood becomes too thick it can damage blood vessels and increase the risk of heart attacks. But a Temple University physicist has discovered that he can thin the human blood by subjecting it to a magnetic field.

8 Jun 2011

Thermo Fisher Scientific launches new triple quadrupole gas chromatography-mass spectrometry system

Thermo Fisher Scientific Inc. has announced the launch of its new triple quadrupole gas chromatography-mass spectrometry (GC-MS/MS) system designed to offer best-in-class selectivity, analytical performance and productivity. The Thermo Scientific TSQ Quantum XLS Ultra delivers the increased matrix selectivity needed for challenging applications that require lower levels of quantitation in extremely complex matrix extracts. With its exceptional sensitivity, easy detection and reliable peak integration, the system provides superior performance for the most difficult of matrix challenges.

From Thermo Fisher Scientific Inc. 7 Jun 2011

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

7 Jun 2011

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

St. Jude Medical, Inc., a global medical device company, today announced the first human implant of its Portico transcatheter aortic heart valve. The procedure was performed by Dr. John Webb, director of cardiac catheterization and interventional cardiology at St. Paul's Hospital in Vancouver, British Columbia.

7 Jun 2011

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.

7 Jun 2011

NYC dermatologist announces website launch of BeautyRx Skincare

To introduce BeautyRx Skincare, Neal Schultz, M.D., board-certified New York City dermatologist, proudly announces the website launch of BeautyRx.com. The site will unveil his new line of skincare products forged from insider advances in cosmeceutical technology, and developed over 10 years with ongoing patient feedback from his 10,000 patient visits per year.

7 Jun 2011

IsoRay completes Iotrex license agreement with Dr. Reddy's

IsoRay, Inc. announced today that it has completed a license agreement with Dr. Reddy's Laboratories for exclusive worldwide licensing rights to Iotrex, a liquid iodine radiation, for use in brain cancer treatment.

7 Jun 2011

OncoSec announces additional evaluation of ElectroImmunotherapy Phase I trial on melanoma

OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that additional evaluation of a previous Phase I trial provided further evidence that a DNA plasmid encoded to produce IL-12 delivered by electroporation into melanoma lesions induces responses to known and novel antigens, resulting in regression of local treated lesions as well as distant untreated lesions.

7 Jun 2011

Guardian Air REME+ system helps reduce germs, allergens and airborne toxins

Hospitals, nursery schools, and other high-traffic indoor spaces have been acting as quiet proving grounds for an advanced new form of air purification. These are normally the kinds of places where germs, allergens and airborne toxins flourish. That's soon going to be a thing of the past.

7 Jun 2011

Incisive Surgical receives U.S. patent for INSORB Absorbable Skin Stapling Technology

Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) issued the Company a key patent for its proprietary INSORB Absorbable Skin Stapling Technology.

7 Jun 2011

Simcere announces settlement agreement with former Jiangsu Quanyi shareholders

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that a settlement agreement with certain former shareholders and directors of Jiangsu Quanyi Biological Technology Stock Co., Ltd. has become effective.

7 Jun 2011

Technology News and Research

Closed-loop artificial pancreas could fight against Type 1 diabetes

Cooperation is key to finding global food security

Self-assembling mini devices now enlisted in nanomedicine revolution

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

Lethal malaria parasite has biochemical weakness

Vaccine candidate produces immune response to antigen in all strains of influenza A

New Westchester Montefiore Laser and Eye Center to offer ophthalmology services

HP partners with nonprofit to help detect malaria outbreaks, improve health monitoring in Botswana

As health care technology advances, costs increase

Magnetic field can reduce blood viscosity, prevent heart attacks

Thermo Fisher Scientific launches new triple quadrupole gas chromatography-mass spectrometry system

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

NYC dermatologist announces website launch of BeautyRx Skincare

IsoRay completes Iotrex license agreement with Dr. Reddy's

OncoSec announces additional evaluation of ElectroImmunotherapy Phase I trial on melanoma

Guardian Air REME+ system helps reduce germs, allergens and airborne toxins

Incisive Surgical receives U.S. patent for INSORB Absorbable Skin Stapling Technology

Simcere announces settlement agreement with former Jiangsu Quanyi shareholders

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News